logo
logo
Sign in

HPV Testing and Pap Test Market Insights on Trends and Growth Forecast by 2032

avatar
Ganesh Shinde
HPV Testing and Pap Test Market Insights on Trends and Growth Forecast by 2032

In 2021, the global HPV Testing and Pap Test Market was estimated to be worth approximately US$ 2.2 billion. With a projected CAGR of 19.3% over the next ten years, the market is expected to be worth approximately US$ 15 billion by the end of 2032. Official strategies and policies, such as the WHO global strategy for cervical cancer elimination, are expected to boost demand for testing. New technologies, government programs, and awareness drives will help boost demand in even low-resource areas.

Cervical Cancer Screening to Continue being the key application for HPV and Pap Test Revenue

Vaginal Cancer cannot be detected with a Pap or HPV tests on their own. They can, however detect cervical cancer and HPV, and pre-cancerous conditions. This is useful since the presence of these can be precursors to cervical cancer.

The US to Command the Larger Proportion of HPV testing and Pap test consumption in the Analysis Period

The US contributed the most to the demand for HPV and Pap Tests. The ACS recommends screening women over 25 at recommended intervals of time. There are also programs that provide free or cheaper testing to women such as the NBCCEDP by the CDC.

HPV testing and Pap Test Market: Competition Insights

HPV Testing and Pap Test providers are focused on increasing the efficiency, accuracy and affordability of their tests and harnessing new technology. The key companies operating include Abbott Laboratories, Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Hologic, Inc., F. Hoffmann-La Roche, Femasys, Inc., Arbor Vita Corporation, NURX, Inc., Seegene, Inc., Thermo Fisher Scientific. Inc., bioMérieux SA

Read More@ https://www.futuremarketinsights.com/reports/hpv-testing-and-pap-test-market

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the HPV Testing and Pap Test Market, presenting historical market data (2017 to 2021) and forecast statistics for the period of 2022 to 2032.

The study reveals essential insights on the basis of by Test Type (HPV Testing, Pap Test), By Application (Vaginal Cancer Screening, Cervical Cancer Screening), By Product Type (Instruments, Consumables, Services), by Technology (PCR, Immunodiagnostics, Other Technologies), across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more